Our research projects

Diabetic retinopathy is a common complication of diabetes that can lead to vision loss. People who have had this condition for more than five years may be at higher risk of developing Alzheimer’s disease. Dr Karis Little aims to better understand the connection between these two conditions by studying the systems in the brain and eye that remove waste. Better understanding what retinopathy and Alzheimer’s disease have in common could provide insights into how retinopathy develops and help identify new treatments.

People living with diabetes are invited to attend routine eye screening appointments to protect their eye health. However, eye drops used during these visits can be uncomfortable and irritating and put people off attending. Professor Scanlon is testing whether a new camera can avoid the need for eye drops in Asian and African-Caribbean people. This research could protect more people from different ethnicities against diabetes-related eye damage. 

Women who develop type 2 diabetes under the age of 40 have a greater risk of complications during pregnancy, including stillbirth. Professor Claire Meek will explore if and how continuous glucose monitoring (CGM) can help these women to have safer pregnancies. This research could reshape future care for women with early-onset type 2 diabetes, helping to make sure they have access to the tools they need.

People with diabetes are at an increased risk of health problems as they age. But doctors don’t usually monitor how older people with diabetes are ageing physically. Professor Bain now wants to develop an Artificial Intelligence (AI) programme that measures the physical ability levels of older people with type 2 diabetes. This could help to better understand the diverse needs of older people with diabetes and use this to make care more personalised.  
 

Our cells have engines, called mitochondria, which power them. In insulin-making cells, the mitochondria tell the cells how and when to release insulin. When blood sugar levels are high, for example when someone has type 2 diabetes, this process stops working properly. Dr Aida Martinez-Sanchez wants to investigate why this happens by studying how the gene Mtfp1 plays a part how beta cell mitochondria behave. Understanding this could help researchers to develop better treatments that may stop type 2 diabetes from progressing.

There are a number of inherited genetic conditions causing very low body fat stores. One of these is congenital generalised lipodystrophy type 2 which can also lead to type 2 diabetes. Dr McIlroy’s shown that gene therapy can treat this condition so he’s now going to study it in more detail. He’s hoping this knowledge will lead to better treatments for type 2 diabetes. 

Our scientists have shown that some adults with type 2 diabetes can go into remission through a low-calorie weight management programme. Dr Sachdev will now explore if the same approach is possible in children with type 2 diabetes. This could lead to a much-needed new treatment that gives children with type 2 the chance to go into remission and the opportunity for a healthier future.  

Type 1 diabetes develops when a person’s immune system attacks and destroys their insulin-making beta cells. Dr Leete will study pancreas samples from people with type 1 diabetes to figure out why the immune system turns on beta cells, and how this process may differ between people, especially those diagnosed at different ages. In the future this could lead to more personalised treatments to delay or prevent type 1 diabetes.

The brain has an important role in measuring and controlling blood sugar levels. In people with diabetes this can go wrong when the brain chooses a level that’s too high. Dr Clemence Blouet wants to find out if there’s a way of developing new treatments that can reprogramme the brain to keep blood sugar at safer levels.